+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Diabetes Care Devices Market by Device Type, Technology, Delivery Mode, Insulin Type, Distribution Channel, End User - Global Forecast to 2030- Product Image
Diabetes Care Devices Market by Device Type, Technology, Delivery Mode, Insulin Type, Distribution Channel, End User - Global Forecast to 2030- Product Image
Sale

Diabetes Care Devices Market by Device Type, Technology, Delivery Mode, Insulin Type, Distribution Channel, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5311206
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Diabetes Care Devices Market grew from USD 3.10 billion in 2024 to USD 3.68 billion in 2025. It is expected to continue growing at a CAGR of 18.64%, reaching USD 8.66 billion by 2030.

Overview of the Diabetes Care Device Landscape

The global diabetes care device market stands at the convergence of rapid technological progression and rising chronic disease prevalence. As patient populations grow and therapeutic regimens become more complex, manufacturers face mounting pressure to deliver devices that are accurate, user-friendly, and seamlessly integrated into daily routines. Regulatory bodies across key regions are accelerating approvals for next-generation systems, while digital health platforms foster data-driven care pathways. Concurrently, supply chains adapt to shifting geopolitical landscapes, demanding agility from stakeholders at every level.

This executive summary synthesizes the most salient developments driving market dynamics. From closed loop automated insulin delivery to advanced continuous glucose monitoring, innovation remains the cornerstone of competitive differentiation. Strategic collaborations among device makers, pharmaceutical firms, and software developers have redefined traditional boundaries. With reimbursement policies evolving to support value-based care, the stage is set for transformative adoption of integrated diabetes management solutions. This analysis distills the critical insights necessary for industry leaders to navigate complexity and seize emerging opportunities.

Critical Transformations Reshaping Diabetes Management

The past five years have witnessed seismic shifts that redefine diabetes care. Closed-loop artificial pancreas systems have transitioned from concept to clinical reality, delivering precise insulin dosing that adapts to real-time glucose metrics. Parallel advances in sensor miniaturization and algorithmic accuracy have propelled continuous glucose monitoring from niche application to standard of care. Cloud-based data platforms and smartphone integration now empower patients with actionable insights, strengthening adherence and improving glycemic control.

Emerging technologies such as digital therapeutics and predictive analytics are forging proactive care pathways. Artificial intelligence-driven models anticipate glycemic excursions before they occur, enabling preventive interventions. Telehealth proliferation has expanded the reach of diabetes specialists, dissolving geographic barriers and fostering personalized coaching. Combined, these transformative forces are not merely enhancing device capabilities-they are redefining the patient experience, aligning clinical outcomes with patient-centric design principles.

Assessing the Cumulative Effect of 2025 US Tariffs

With the introduction of new United States tariffs in 2025, the diabetes device supply chain faces unprecedented cost pressures. Tariffs on key components have elevated manufacturing costs for sensors, infusion sets, and microfluidic pump mechanisms. In response, manufacturers are reassessing sourcing strategies, diversifying suppliers across Asia-Pacific and Latin America to mitigate exposure to escalating import duties.

These cost headwinds have prompted device makers to renegotiate contracts and explore near-shoring options. At the same time, value engineering initiatives aim to preserve device performance while optimizing bill of materials. Regulatory agencies are collaborating with industry to streamline approval pathways for redesigned components. Despite near-term margin compression, the industry’s adaptive response underscores its resilience and commitment to ensuring uninterrupted patient access to critical diabetes management technologies.

Deep Dive into Market Segmentation Insights

Market segmentation reveals the intricate architecture of the diabetes care device ecosystem and highlights areas of strategic focus. By device type, the landscape encompasses artificial pancreas systems-spanning both full closed loop and hybrid closed loop configurations-and a diverse range of glucose monitoring modalities including continuous glucose monitoring, flash glucose monitoring, and self-monitoring blood glucose. Injection aids such as infusion sets, pen needles, and syringe needles cater to varying patient preferences, while insulin pens offer prefilled disposable, reusable, and emerging smart pen formats. Insulin pumps bifurcate into patch pumps and tubed pumps, complemented by traditional insulin syringes.

A deeper dive by technology underscores the prominence of continuous glucose monitoring, differentiated into real-time and retrospective systems, alongside flash monitoring and self-monitoring solutions that incorporate glucose meters, lancets, and test strips. Delivery mode segmentation contrasts continuous infusion systems with intermittent delivery approaches. Insulin type categorization spans intermediate acting, long acting-with its detemir and glargine subtypes-rapid acting encompassing aspart, glulisine, and lispro, short acting, and ultra long acting variants. Distribution channels extend from direct sales and hospital pharmacies to online platforms and retail pharmacies, the latter comprising chain and independent outlets. Finally, end user segmentation captures diagnostic centers, home care environments, and hospitals and clinics, with specialized diabetes clinics and general clinics making up the latter.

Key Regional Variations and Growth Drivers

Regional dynamics exert a profound influence on innovation trajectories and market adoption curves. In the Americas, policy incentives for digital health reimbursement and established distribution networks support rapid uptake of next-generation devices. North American venture capital investment fuels startup ecosystems, accelerating commercialization of novel sensor technologies and wearable pump designs.

Within Europe, Middle East & Africa, regulatory harmonization under the In Vitro Diagnostic Regulation and Medical Device Regulation fosters a consistent framework for market entry, while mobile health adoption varies across territories. Emerging markets in the GCC and North Africa present high-growth avenues for cost-effective monitoring solutions, driven by rising diabetes prevalence and expanding healthcare infrastructure.

The Asia-Pacific region is characterized by dual dynamics: mature markets in Japan and South Korea that prioritize premium, sensor-driven therapies, and rapidly evolving markets in Southeast Asia and India where affordability and distribution reach determine success. Pan-regional collaborations and local manufacturing initiatives aim to reconcile quality standards with cost imperatives, shaping a complex yet opportunity-rich landscape.

Profiling Leading Innovators in the Device Sector

Leading innovators in the diabetes device sector are distinguished by their integrated portfolios, strategic partnerships, and forward-looking research commitments. Established sensor manufacturers invest heavily in next-generation continuous monitoring platforms that combine multi-analyte detection with extended wear protocols. Insulin delivery companies are expanding beyond pump hardware to develop software ecosystems that leverage machine learning for dosing optimization.

Collaborations between device pioneers and pharmaceutical corporations have given rise to co-developed combination therapies that embed glucose monitoring sensors within insulin delivery devices. Meanwhile, emerging players focus on disruptive modalities such as implantable sensors and closed loop algorithms optimized through adaptive learning. Across the competitive landscape, proprietary data analytics platforms represent a key differentiator, enabling companies to derive real-world evidence from patient interactions and refine algorithmic performance over time.

Strategic Recommendations for Market Leadership

Industry leaders must adopt a multi-pronged strategy to maintain competitive advantage in a rapidly evolving market. First, priority should be given to integrating closed loop functionalities with user-centric design enhancements that minimize patient burden. Investments in artificial intelligence and cloud-native analytics will drive the next wave of personalized therapy optimization.

Second, diversification of supply chains through geographic dispersion and strategic partnerships will buffer against tariff volatility and component shortages. Companies should explore co-manufacturing arrangements in Asia-Pacific and Eastern Europe to balance cost efficiency with quality assurance.

Third, forging alliances with payers and healthcare systems to establish value-based reimbursement frameworks will accelerate adoption of premium devices. Demonstrating real-world clinical and economic benefits through robust evidence generation will be critical to securing long-term contracts.

Finally, an intensified focus on emerging markets-leveraging digital distribution channels and localized service models-will unlock new patient populations and revenue streams. Collaborative initiatives with regional healthcare providers can facilitate technology transfer and build sustainable growth trajectories.

Robust Research Methodology Underpinning the Analysis

This analysis draws upon a twin-track research framework combining primary expert interviews and comprehensive secondary research. In-depth discussions with endocrinologists, device engineers, and regulatory specialists provided nuanced perspectives on technology adoption, clinical validation, and market access barriers. Secondary sources included peer-reviewed literature, regulatory filings, patent databases, and corporate disclosures, ensuring a rigorous foundation of validated data.

Quantitative segmentation was underpinned by a structured taxonomy encompassing device type, technology, delivery mode, insulin formulation, distribution channel, and end user. Regional market dynamics were mapped through country-level policy analysis and distribution channel audits. All insights underwent a stringent peer-review process to verify accuracy and relevance. The methodology emphasizes transparency and reproducibility, enabling stakeholders to trace insights back to their original data sources.

Synthesis of Insights and Market Outlook

The diabetes care device market stands poised at the intersection of technological innovation and evolving healthcare paradigms. Closed loop systems, sensor advancements, and data analytics are converging to deliver truly personalized management solutions. While tariff pressures and supply chain complexities present challenges, strategic adaptability and diversified sourcing will preserve market momentum.

Regional heterogeneity underscores the need for tailored approaches: premium, data-rich devices will thrive in mature economies, while cost-optimized solutions catalyze growth in emerging markets. Leading firms that harness integrated portfolios, evidence-based reimbursement strategies, and agile operations will define the next chapter of diabetes care. This executive summary equips decision-makers with the essential insights to navigate complexity, capitalize on innovation, and drive sustainable impact.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Device Type
    • Artificial Pancreas Systems
      • Full Closed Loop
      • Hybrid Closed Loop
    • Glucose Monitoring Devices
      • Continuous Glucose Monitoring
      • Flash Glucose Monitoring
      • Self Monitoring Blood Glucose
    • Injection Aids
      • Infusion Sets
      • Pen Needles
      • Syringe Needles
    • Insulin Pens
      • Prefilled Disposable Pens
      • Reusable Pens
      • Smart Pens
    • Insulin Pumps
      • Patch Pumps
      • Tubed Pumps
    • Insulin Syringes
  • Technology
    • Continuous Glucose Monitoring
      • Real Time Continuous Glucose Monitoring
      • Retrospective Continuous Glucose Monitoring
    • Flash Glucose Monitoring
    • Self Monitoring Blood Glucose
      • Glucose Meters
      • Lancets
      • Test Strips
  • Delivery Mode
    • Continuous Delivery
    • Intermittent Delivery
  • Insulin Type
    • Intermediate Acting
    • Long Acting
      • Detemir
      • Glargine
    • Rapid Acting
      • Aspart
      • Glulisine
      • Lispro
    • Short Acting
    • Ultra Long Acting
  • Distribution Channel
    • Direct Sales
    • Hospital Pharmacies
    • Online Channels
    • Retail Pharmacies
      • Chain Pharmacies
      • Independent Pharmacies
  • End User
    • Diagnostic Centers
    • Home Care
    • Hospitals And Clinics
      • Diabetes Clinics
      • General Clinics
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Abbott Laboratories
  • Medtronic plc
  • Roche Holding AG
  • Dexcom, Inc.
  • Becton, Dickinson and Company
  • Insulet Corporation
  • Tandem Diabetes Care, Inc.
  • Terumo Corporation
  • Kyowa Kirin Co., Ltd.
  • Ypsomed Holding AG

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Diabetes Care Devices Market, by Device Type
8.1. Introduction
8.2. Artificial Pancreas Systems
8.2.1. Full Closed Loop
8.2.2. Hybrid Closed Loop
8.3. Glucose Monitoring Devices
8.3.1. Continuous Glucose Monitoring
8.3.2. Flash Glucose Monitoring
8.3.3. Self Monitoring Blood Glucose
8.4. Injection Aids
8.4.1. Infusion Sets
8.4.2. Pen Needles
8.4.3. Syringe Needles
8.5. Insulin Pens
8.5.1. Prefilled Disposable Pens
8.5.2. Reusable Pens
8.5.3. Smart Pens
8.6. Insulin Pumps
8.6.1. Patch Pumps
8.6.2. Tubed Pumps
8.7. Insulin Syringes
9. Diabetes Care Devices Market, by Technology
9.1. Introduction
9.2. Continuous Glucose Monitoring
9.2.1. Real Time Continuous Glucose Monitoring
9.2.2. Retrospective Continuous Glucose Monitoring
9.3. Flash Glucose Monitoring
9.4. Self Monitoring Blood Glucose
9.4.1. Glucose Meters
9.4.2. Lancets
9.4.3. Test Strips
10. Diabetes Care Devices Market, by Delivery Mode
10.1. Introduction
10.2. Continuous Delivery
10.3. Intermittent Delivery
11. Diabetes Care Devices Market, by Insulin Type
11.1. Introduction
11.2. Intermediate Acting
11.3. Long Acting
11.3.1. Detemir
11.3.2. Glargine
11.4. Rapid Acting
11.4.1. Aspart
11.4.2. Glulisine
11.4.3. Lispro
11.5. Short Acting
11.6. Ultra Long Acting
12. Diabetes Care Devices Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Hospital Pharmacies
12.4. Online Channels
12.5. Retail Pharmacies
12.5.1. Chain Pharmacies
12.5.2. Independent Pharmacies
13. Diabetes Care Devices Market, by End User
13.1. Introduction
13.2. Diagnostic Centers
13.3. Home Care
13.4. Hospitals and Clinics
13.4.1. Diabetes Clinics
13.4.2. General Clinics
14. Americas Diabetes Care Devices Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Diabetes Care Devices Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Diabetes Care Devices Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Abbott Laboratories
17.3.2. Medtronic plc
17.3.3. Roche Holding AG
17.3.4. Dexcom, Inc.
17.3.5. Becton, Dickinson and Company
17.3.6. Insulet Corporation
17.3.7. Tandem Diabetes Care, Inc.
17.3.8. Terumo Corporation
17.3.9. Kyowa Kirin Co., Ltd.
17.3.10. Ypsomed Holding AG
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. DIABETES CARE DEVICES MARKET MULTI-CURRENCY
FIGURE 2. DIABETES CARE DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. DIABETES CARE DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DIABETES CARE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. DIABETES CARE DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. DIABETES CARE DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DIABETES CARE DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DIABETES CARE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY FULL CLOSED LOOP, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY HYBRID CLOSED LOOP, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY FLASH GLUCOSE MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INFUSION SETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PEN NEEDLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SYRINGE NEEDLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PREFILLED DISPOSABLE PENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY REUSABLE PENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SMART PENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PATCH PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TUBED PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY REAL TIME CONTINUOUS GLUCOSE MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY RETROSPECTIVE CONTINUOUS GLUCOSE MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY FLASH GLUCOSE MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE METERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY LANCETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TEST STRIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INTERMITTENT DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INTERMEDIATE ACTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DETEMIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GLARGINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ASPART, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GLULISINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY LISPRO, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SHORT ACTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ULTRA LONG ACTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DIABETES CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 109. CANADA DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 110. CANADA DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 111. CANADA DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 112. CANADA DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2030 (USD MILLION)
TABLE 113. CANADA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 114. CANADA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 115. CANADA DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 116. CANADA DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2030 (USD MILLION)
TABLE 117. CANADA DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2030 (USD MILLION)
TABLE 118. CANADA DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 119. CANADA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 120. CANADA DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2030 (USD MILLION)
TABLE 121. CANADA DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2030 (USD MILLION)
TABLE 122. CANADA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. CANADA DIABETES CARE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 124. CANADA DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. CANADA DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 126. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 127. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 128. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 129. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2030 (USD MILLION)
TABLE 130. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 131. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 132. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2030 (USD MILLION)
TABLE 134. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2030 (USD MILLION)
TABLE 135. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 136. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 137. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2030 (USD MILLION)
TABLE 138. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2030 (USD MILLION)
TABLE 139. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 141. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 160. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 161. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 162. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 163. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2030 (USD MILLION)
TABLE 164. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2030 (USD MILLION)
TABLE 168. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2030 (USD MILLION)
TABLE 169. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 170. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 171. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2030 (USD MILLION)
TABLE 172. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2030 (USD MILLION)
TABLE 173. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 175. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2030 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2030 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 196. UNITED KINGDOM DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 198. UNITED KINGDOM DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 200. UNITED KINGDOM DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 202. UNITED KINGDOM DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2030 (USD MILLION)
TABLE 204. UNITED KINGDOM DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 206. UNITED KINGDOM DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2030 (USD MILLION)
TABLE 208. UNITED KINGDOM DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM DIABETES CARE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 210. UNITED KINGDOM DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 212. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 213. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 214. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 215. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2030 (USD MILLION)
TABLE 216. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 217. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 218. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 219. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2030 (USD MILLION)
TABLE 220. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2030 (USD MILLION)
TABLE 221. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 222. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 223. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2030 (USD MILLION)
TABLE 224. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2030 (USD MILLION)
TABLE 225. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 226. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 227. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 229. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 230. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 231. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 232. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2030 (USD MILLION)
TABLE 233. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 234. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 235. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 236. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2030 (USD MILLION)
TABLE 237. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2030 (USD MILLION)
TABLE 238. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 239. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 240. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2030 (USD MILLION)
TABLE 241. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2030 (USD MILLION)
TABLE 242. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 243. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 244. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 246. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 247. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 248. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 249. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2030 (USD MILLION)
TABLE 250. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 251. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 252. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 253. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2030 (USD MILLION)
TABLE 254. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2030 (USD MILLION)
TABLE 255. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 256. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 257. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2030 (USD MILLION)
TABLE 258. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2030 (USD MILLION)
TABLE 259. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 260. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 261. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 263. ITALY DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 264. ITALY DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 265. ITALY DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 266. ITALY DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2030 (USD MILLION)
TABLE 267. ITALY DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 268. ITALY DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 269. ITALY DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 270. ITALY DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2030 (USD MILLION)
TABLE 271. ITALY DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2030 (USD MILLION)
TABLE 272. ITALY DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 273. ITALY DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 274. ITALY DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2030 (USD MILLION)
TABLE 275. ITALY DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2030 (USD MILLION)
TABLE 276. ITALY DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 277. ITALY DIABETES CARE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 278. ITALY DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 279. ITALY DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 280. SPAIN DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 281. SPAIN DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 282. SPAIN DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 283. SPAIN DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2030 (USD MILLION)
TABLE 284. SPAIN DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 285. SPAIN DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 286. SPAIN DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 287. SPAIN DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2030 (USD MILLION)
TABLE 288. SPAIN DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2030 (USD MILLION)
TABLE 289. SPAIN DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 290. SPAIN DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 291. SPAIN DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2030 (USD MILLION)
TABLE 292. SPAIN DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2030 (USD MILLION)
TABLE 293. SPAIN DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 294. SPAIN DIABETES CARE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 295. SPAIN DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 296. SPAIN DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2030 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 303. UNITED ARAB EMIRATES DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 304. UNITED ARAB EMIRATES DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2030 (USD MILLION)
TABLE 305. UNITED ARAB EMIRATES DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2030 (USD MILLION)
TABLE 306. UNITED ARAB EMIRATES DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 307. UNITED ARAB EMIRATES DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 308. UNITED ARAB EMIRATES DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2030 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES DIABETES CARE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 314. SAUDI ARABIA DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 316. SAUDI ARABIA DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2030 (USD MILLION)
TABLE 318. SAUDI ARABIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA DIABETES CARE DEVICES

Companies Mentioned

The companies profiled in this Diabetes Care Devices market report include:
  • Abbott Laboratories
  • Medtronic plc
  • Roche Holding AG
  • Dexcom, Inc.
  • Becton, Dickinson and Company
  • Insulet Corporation
  • Tandem Diabetes Care, Inc.
  • Terumo Corporation
  • Kyowa Kirin Co., Ltd.
  • Ypsomed Holding AG

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages194
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.68 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.66 Billion
Compound Annual Growth Rate18.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Diabetes Care Devices, Forecast to 2028 - Product Image

Diabetes Care Devices, Forecast to 2028

  • Report
  • Global
From
Diabetes Care Devices Market Report by Type, Distribution Channel, End User, and Region 2024-2032 - Product Image

Diabetes Care Devices Market Report by Type, Distribution Channel, End User, and Region 2024-2032

  • Report
  • 144 Pages
  • Global
From
Diabetes Care Devices - Global Strategic Business Report - Product Image

Diabetes Care Devices - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
Diabetes Care Devices Market Report 2025 - Product Image

Diabetes Care Devices Market Report 2025

  • Report
  • 400 Pages
  • Global
From
Diabetes Care Devices Market by Product Type, Technology, Distribution Channel, and End-User - Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles and Market Forecast, 2025-2035 - Product Image

Diabetes Care Devices Market by Product Type, Technology, Distribution Channel, and End-User - Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles and Market Forecast, 2025-2035

  • Report
  • 235 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.